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AbstrAct
Objectives The study sought to examine the implementation 
of sick day guidance cards designed to prevent acute kidney 
injury (AKI), in primary care settings.
Design Qualitative semistructured interviews were 
conducted and comparative analysis informed by 
normalisation process theory was undertaken to 
understand sense-making, implementation and appraisal 
of the cards and associated guidance.
setting A single primary care health setting in the North 
of England.
Participants 29 participants took part in the qualitative 
evaluation: seven general practitioners, five practice 
nurses, five community pharmacists, four practice 
pharmacists, two administrators, one healthcare assistant 
and five patients.
Intervention The sick day guidance intervention was 
rolled out (2015–2016) in general practices (n=48) and 
community pharmacies (n=60). The materials consisted of 
a ‘medicine sick day guidance’ card, provided to patients 
who were taking the listed drugs. The card provided advice 
about medicines management during episodes of acute 
illness. An information leaflet was provided to healthcare 
practitioners and administrators suggesting how to use 
and give the cards.
results Implementation of sick day guidance cards to 
prevent AKI entailed a new set of working practises across 
primary care. A tension existed between ensuring reach in 
administration of the cards to at risk populations while being 
confident to ensure patient understanding of their purpose 
and use. Communicating the concept of temporary cessation 
of medicines was a particular challenge and limited their 
administration to patient populations at higher risk of AKI, 
particularly those with less capacity to self-manage.
conclusions Sick day guidance cards that focus solely 
on medicines management may be of limited patient 
benefit without adequate resourcing or if delivered as a 
standalone intervention. Development and evaluation of 
primary care interventions is urgently warranted to tackle 
the harm associated with AKI.
IntrODuctIOn
Addressing the harm related to acute kidney 
injury (AKI) is a worldwide priority.1 AKI 
is characterised as a sudden reduction in 
kidney function over hours or days.2–4 It is 
a marker of illness severity and is seen as a 
‘force multiplier,’ complicating episodes of 
acute illness.3 As a clinical syndrome, the 
majority of cases of AKI are due to a combi-
nation of underlying infection, hypovolaemia 
(low circulatory blood volume), hypotension 
(low blood pressure) and medication effects.3 
Addressing these potentially modifiable 
factors are central to both the prevention 
and management of AKI and its associated 
burden.2–4 
Across the UK, patient safety initiatives have 
been established to address the morbidity, 
mortality and costs linked to AKI.2 5–7 In Scot-
land, informed by findings from a primary 
care study conducted by NHS Highland, 
medicine sick day rules have been made 
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Research
strengths and limitations of this study
 ► Using normalisation process theory has allowed 
important insights to emerge into the comprehension, 
use and appraisal of the acute kidney injury  (AKI) 
sick day card initiative.
 ► Interviews with a range of professionals (general 
practitioners, nurses, community and practice-
based pharmacists, a healthcare assistant, 
practice administrators) and patients enhanced 
understanding of the individual and collective 
working practises surrounding the professional 
implementation AKI sick day guidance cards.
 ► Patient recruitment to the qualitative evaluation 
via general practice was slow and yielded only five 
patient-participants. This limited the  analysis of 
patient use of sick day guidance in everyday life.
 ► Future study design would benefit from greater 
alignment between quantitative and qualitative 
elements of an evaluation.
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available nationally through the Scottish Patient Safety 
Programme.6 8 The introduction of medicine sick day rules 
relates to NHS Scotland Polypharmacy Guidance as well 
as national guidance, published by the National Institute 
for Health and Care Excellence (NICE) and by the Royal 
College of Physicians of Edinburgh UK.4 9 10 These publi-
cations highlight a need to consider temporary cessation 
of medicines at times of acute illness.4 9 10 That is, during 
these episodes, ‘any drug that reduces blood pressure, 
circulating volume or renal blood flow’ increases the risk of 
AKI.3 Medicines that exacerbate this risk include non-ste-
roidal anti-inflammatory drugs (NSAIDS), diuretics, ACE 
inhibitors and angiotensin II receptor blockers (ARBs).3 
In addition, the Scottish medicine sick day rules refer to 
the temporary cessation of metformin, which may accu-
mulate at times of reduced kidney function, resulting in 
an increased risk of adverse effects.6 The NHS Scotland 
‘Medicine Sick Day Rules’ cards were developed through 
extraction of NHS Scotland Polypharmacy Guidance 
(2012) and were ‘designed with input from pharmacists, 
doctors and patients’.10 11 They provide instructions on 
temporarily stopping these specific types of medicines 
during episodes of acute illness.6 8
In England, within NHS England’s Patient Safety 
Domain, the Think Kidneys Programme (https://
www. thinkkidneys. nhs. uk) was established to tackle the 
harm associated with AKI.12 Through the programme, 
resources have been developed for primary and secondary 
care, including an Interim Position Statement on ‘Sick 
Day’ Guidance, which highlights a clinical equipoise 
surrounding the systematic implementation of sick day 
guidance.13
It was in this wider context that a Clinical Commis-
sioning Group (CCG), in partnership with the local 
hospital, embarked on service improvement initiatives to 
address the harm associated with AKI. Informed directly 
by the Scottish approach in conjunction with national 
guidance,4 6 8 the CCG sought to implement the use of 
sick day guidance across general practices and commu-
nity pharmacies within its boundaries. The Sick Day Guid-
ance Project including an overview of the organisation of 
primary healthcare in England is outlined in table 1 as 
well as figures 1A,B. In accordance with NHS England 
Think Kidneys guidance, the project entailed formal 
evaluation. With a view to providing a platform for future 
larger scale evaluation, the study sought to explore and 
understand processes underpinning the implementation 
of sick day guidance in primary care.
MethODs
study design
Aligned with the project objectives, normalisation process 
theory (NPT) provided a sensitising framework to inform 
the topic guide and explore the context, administration, 
interpretation and use of sick day guidance cards across a 
single primary healthcare setting in England.14 15 NPT is a 
theory of implementation developed through an in-depth 
analysis of chronic illness care in general practice.14 It is a 
sociological theory that provides a structure to explore the 
individual and group work that people do surrounding 
the implementation of a complex intervention.14–16
Data sampling
To explore the trajectory of implementation across 
the CCG, all general practices (n=48), community 
pharmacies (n=60) and practice-based pharmacists 
(n=4) involved in the project were invited to take part 
in the evaluation. Information packs were provided 
to explain what involvement entailed. To facilitate 
patient-participant engagement, general practices 
and community pharmacists were asked to provide 
information packs to patients who had received a 
card via a health practitioner. The final data sample 
of 29 interviews comprised: seven general practi-
tioners (GPs), five practice nurses, five patients, five 
community pharmacists, four practice-based pharma-
cists, two managers (one medical practice manager 
and one community pharmacy manager) and a health-
care assistant, a person qualified to carry out routine 
healthcare tasks.
Data collection
Two qualitative researchers (A-MM; RE) conducted the 
29 semistructured interviews. These were conducted 
with participants across the CCG between June 2015 
and April 2016. Participants received an approved 
participant information sheet and consent form via 
post or email. Both were read by the researcher prior 
to interview and participants had the opportunity to 
ask questions and have them answered satisfactorily. 
Informed consent was gained before each interview. 
Interviews with the GPs, practice nurses, adminis-
trators and the healthcare assistant took place in 
private locations within their general practices. Inter-
views with community pharmacists were also held at 
private locations at their places of work. Interviews 
with patients occurred at their homes. Interviews with 
three of the practice-based pharmacists took place at 
their place of work; one took place on the phone. The 
two researchers did not know any of the participants 
prior to interview. The interviews ranged in length 
from 9 to 66 minutes (median=33 min). They were 
digitally audio-recorded in compliance with partici-
pants’ consent and professionally transcribed.
Interview topic guides were developed to explore the 
work being undertaken by professionals and patients 
surrounding the use of sick day guidance cards. NPT 
was used to inform the areas of questioning.15 Topics 
for the health practitioners included previous knowl-
edge of AKI and involvement in kidney health initia-
tives, their role in the intervention, sense-making 
and experiences of implementing and appraising 
the administration of sick day guidance cards. For 
patient-participant interviews, topics included: sense-
making around health and illness, the context of card 
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Figure 1 (A) and (B) Sick day guidance card used during this project. The NHS Highland sick day rules card was reproduced 
with new logos.6 8 ARB, angiotensin II receptor blockers; GP, general practitioner; NSAIDs, non-steroidal anti-inflammatory 
drugs. 
giving and guidance explanation and comprehension 
and use of the guidance (table 2). Field notes about 
the encounter were written immediately after leaving 
the interview site and used to inform the analysis. 
Participants were asked if they wanted to receive a 
transcript post interview to check for accuracy, none 
did.
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Data analysis
A-MM developed a thematic analysis framework using the 
evaluation objectives and the four core constructs of NPT 
to understand implementation.14 15 NPT is concerned 
with social action rather than attitudes, and its four core 
constructs are coherence (sense-making), cognitive 
participation (relational work), collective action (oper-
ational work) and reflexive monitoring (appraisal).14 15 
The NPT constructs provided a pragmatic structure to 
consider different types of work surrounding the imple-
mentation of sick day guidance cards. Furthermore, it 
provided a sensitising framework to explore the rela-
tionships between different types of work being under-
taken.17 The questions asked of the health practitioner 
interview data included:
 ► how do they make sense of implementing the sick day 
card initiative? (coherence)
 ► what work have they done to implement the initiative? 
(operational work)
 ► how is the initiative being communicated or enacted 
by local others? (relational work)
 ► what judgments have been made about the initiative? 
(appraisal)
The questions we asked of the patient-participant data 
included:
 ► how does the participant make sense of health and 
illness? (coherence)
 ► what was the context of the participant receiving a 
card and guidance?
 ► how did they make sense of the card and implement 
the guidance in their day to day lives? (coherence, 
operational, relational work)
 ► how did they value the intervention? (appraisal).
As the interviews were completed and transcribed, data 
from each account were grouped according to role, which 
resulted in six datasets: GP, practice nurse and healthcare 
assistant, administration, community pharmacist, prac-
tice pharmacist and patient-participant. Thematic anal-
ysis using the transcripts, the audio recordings and the 
field notes was carried out by A-MM and TB. Each inter-
view within a role group was analysed, and the findings 
were compared with those within the same group. Vari-
ations and similarities in context, sense-making, imple-
mentation and appraisal of the card were noted, explored 
and compared with the findings within and between role 
groups to enhance broader understanding.18 Key themes 
and tensions underpinning implementation emerged 
through comparative, contextual analysis of individual 
and collective working practises underpinning introduc-
tion of sick day guidance cards.
results
A version of the findings of this paper is included in a 
wider report that has been provided to the funding organ-
isation.19 AKI was viewed as a new phenomenon and the 
implementation of sick day guidance cards entailed a 
new set of working practises. Analysis indicated that AKI 
prevention guidance was not necessarily a straightforward 
concept to understand or to communicate. Health prac-
titioners thought the cards required some knowledge of 
illness symptoms and medicines and that patients had 
to decide how severe the symptoms were before acting 
or restarting their medication. One practice pharmacist 
stated:
‘…patients don’t understand what fever is…they think that 
if they’ve got a headache it’s fever…we’re trying to explain 
and they don’t understand, or they say well, if I had a bout 
of diarrhoea do I stop the medication…it’s severe. Well, 
what is severe, you know? Obviously it’s very subjective…’ 
(SKHIP13PP).
Comparative analysis highlighted a tension between the 
need to achieve reach to the populations deemed at risk 
(ie, those taking medicines specified on the card) and at 
the same time ensure comprehension concerning use of 
the guidance. There was evidence that this tension influ-
enced the implementation of the sick day guidance inter-
vention. The following sections describe the different 
approaches employed.
Administration of the sick day guidance card in conjunction 
with face-to-face communication
A common theme was health professionals and patients 
valuing the need to explain the guidance in person. One 
patient reflected:
‘I don't think that it should be just put on a counter… I 
don't think, number one, they’ll read it, number two, they’ll 
digest what’s on it, or number three, they’ll apply it to 
themselves’ (SKHIP22PA).
A practice nurse thought dialogue was also important 
to reduce miscommunication, avoid patient confusion 
and additional GP workload:
‘I always explain …There’s no point giving someone a 
card if they don’t understand what it’s for…my grandma 
wouldn’t understand that. She’d probably misinterpret that 
and…stop taking everything’ (SKHIP25PN).
Analysis of health practitioner and patient accounts 
revealed that patients responded to the guidance in a 
variety of ways, not always as intended. One patient partic-
ipant used the terms sickness and illness interchangeably 
and spoke of different classifications of illness. She asked 
which type the guidance card was referring to, to be confi-
dent of following the instructions properly:
‘What do you define as illness…? Well, I suppose I don't 
know… I've got arthritis, that's not an illness it's just a 
thing of life when you get older…I've had spinal surgery, but 
they're not illnesses…' (SKHIP22PA).
Two health practitioners reported instances of patients 
with medication-associated diarrhoea stopping their 
tablets since receiving a card. This unintended conse-
quence of the initiative lead to those patients being 
prescribed alternative medication to alleviate the side 
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effect. A couple of patient-participant accounts revealed 
a lack of willingness to follow the guidance as it had not 
been implemented by their hospital specialist, whose 
opinion they trusted, and they did not want to make their 
condition worse:
‘I’d rather feel sick than have a problem with the high blood 
pressure…’ (SKHIP31PA).
The concept of temporary cessation of medicines 
required careful consideration, for example when to 
stop, restart and what dosage to reinstate:
‘We don’t have enough data or…best practice… if you stop 
the metformin or whatever medication how long do you stop 
it for…? Then after a week are you going to restart them 
again on the ten milligram or are you going to start them on 
the 1.5, the 2.5…?’ (SKHIP14GP).
Although valued by the health practitioners inter-
viewed, implementation of sick day guidance initia-
tive demanded extra work. In general practice, this was 
deemed less problematic when it fitted into existing long-
term condition review appointments, particularly with 
practice nurses or healthcare assistants. In community 
pharmacies, implementation sat more readily within face-
to-face medication review appointments or opportunistic 
over-the-counter interactions, including the purchase of 
NSAIDS such as ibuprofen. One community pharmacist 
used the purchase of antidiarrhoeal or sickness medica-
tions as an opportunity to administer AKI guidance:
‘…when people have been coming in to buy stuff for sickness 
or diarrhoea… If it turns out that they're on one of the 
medications that’s on the card, then we’ll give them a card 
then as well and explain about it’ (SKHIP5CP).
There were limits to the implementation of sick day 
guidance in patient populations deemed at increased 
risk of AKI. Concerns were expressed across the health 
professionals interviewed that the cards and tempo-
rary cessation of medications were not suitable for 
patients with cognitive impairments such as Alzheim-
er’s disease, reduced literacy in English, those with 
advanced learning difficulties or visual impairments 
or for elderly housebound patients taking multiple 
medicines. One community pharmacist commented 
on the difficulties facing patients and carers using 
dosette box (blister pack) systems:
‘they (patients) might have four or five tiny little white ones, 
and then if they’re elderly or they can’t see the markings, they 
don’t know what tablet they should be stopping…. if it was 
a family member looking out for it, that would be I guess 
possible, but a lot of the carers are not allowed to alter any 
medication’ (SKHIP7CP).
Administration of sick day guidance cards to patients in 
conjunction with telephone consultations
Phase Two of the project entailed Practice Pharmacists 
supporting the implementation of the sick day guidance 
cards in general practices (see table 1). All of the four 
CCG employed pharmacists valued and engaged with 
the project. However, they outlined difficulties fitting 
the implementation in with their pre-existing workload. 
There were more patients to work with than anticipated, 
and the searches, writing to patients, communicating with 
them and feeding the results back to GPs took longer to 
complete than the pharmacists described having time for.
To implement the project in this context, a decision 
was made to have telephone conversations with patients 
rather than face-to-face interactions. However, this 
created additional challenges. The phone calls took as 
long as the face-to-face encounters as the pharmacists 
expressed a professional need to do things ‘properly’. They 
reported patients not always being happy to talk with a 
perceived stranger on the phone about their health. 
Patient understanding was harder to assess and patients 
did not necessarily agree to enact the guidance if they 
became ill. Unlike the face-to-face GP and practice nurse 
consultations, patients on the other end of the phone had 
no prior trusting relationship with the practice pharma-
cist. One pharmacist tried to mitigate some of these issues 
by talking with a GP in advance of phoning:
‘…I’m not going to just pick up the phone and ring this 
patient now, I’m going to ask the GP what he thinks… for 
the slightly elderly- some patients, perhaps mental health 
issues….They obviously know their patients much better 
than I do so I always take their advice’ (SKHIP11PP).
The community pharmacists also spoke of the difficul-
ties of assessing patient comprehension in this way:
‘I’ve had to phone patients …if you’ve got a query or the 
prescription will be changed or we’ll want to question 
something …sometimes they’re on the ball, they completely 
know, and sometimes they’re just so confused’ (SKHIP7CP).
sick day guidance cards being administered without verbal or 
written communication
Instructions administered to health practitioners 
(figure 2) stressed the need for dialogue with patients to 
check understanding. However, accounts indicated that 
this did not always occur. Reasons included other work 
demands during a practice-based consultation, limited 
time for dialogue, forgetting to discuss it and some lack 
of confidence about what to say, partly because of the 
limited evidence base and so as not to confuse patients, 
especially those who were less fluent in English:
‘we have quite a lot of different ethnicities here…they’ve got 
limited English I think they’re not quite sure and it takes 
quite a while explaining …about what medicines to stop, 
when to stop it, when to restart it…’ (SKHIP10PN).
Though the community pharmacists were willing to 
talk with patients about the guidance cards, time short-
ages and other work demands impinged on implementa-
tion. One community pharmacist stated:
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Figure 2 Guidance provided to health practitioners (shortened form). GP, general practitioner; NSAIDs, non-steroidal anti-
inflammatory drugs.
‘Half the time it's remembering to do it because you're 
thinking about that many different things’ (SKHIP5CP).
In addition, they did not always have face-to-face contact 
with patients:
‘we’ve got like 900 of our own patients and we just make 
the packs and then send them out and delivery, so we don’t 
actually have that much patient contact’ (SKHIP7CP).
Some health practitioners felt that the cards were 
self-explanatory. One practice nurse said:
‘vomiting is vomiting and diarrhoea is diarrhoea’ 
(SKHIP25PN).
However, others did not agree. One GP thought it was 
really important to provide patients with written material 
to aid understanding and compliance:
‘with certain other sort of medicine regimes, we ask them to 
stop temporarily if there’s a drug interaction and patients 
are okay with that, as long as you give them sort of written 
instructions and they know exactly why they’re stopping. A lot 
of it is to do with the understanding. They don’t like stopping 
things if they don’t understand why…’ (SKHIP20GP).
A couple of patient accounts referred to finding cards 
in public information areas of medical practices and 
community pharmacies. One patient who found a card 
in this manner wanted to share the sick day guidance 
message:
‘…I went into the pharmacy last week, they were on the 
counter…I picked one up and brought it home …I think 
it's such a good idea that I've given one to my sister’ 
(SKHIP22PA).
communication of AKI risk, but limited use of a sick day 
guidance card
One GP worked exclusively with patients in care homes 
across the CCG, which included patients who were diag-
nosed with cognition limiting conditions such as dementia. 
Though the guidance messages were deemed pertinent to 
these groups of patients more vulnerable to AKI, their use 
was limited due to a potential lack of understanding:
‘So we have the card. We didn’t use it a lot…We used it to 
give to the carers. I used it to give to a few of the patients that 
have capacity’ (SKHIP14GP).
The need for appropriate training for carers, nursing 
staff and associated social workers was raised, beyond 
the level of the sick day guidance card. Specifically there 
was felt to be an ongoing need for health practitioners 
to highlight the importance of fluid management in 
conjunction with medicines management:
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‘…they (dementia patients) ended up not eating or 
drinking, worsening of the renal function and become 
unwell and they end up in hospital…’ So it’s working with 
the carer as well to understand…. It’s serious things that 
they might die from, not being hydrated’ (SKHIP14GP).
DIscussIOn
Principal findings
Implementation of sick day guidance cards to prevent 
community based AKI entailed a new set of working 
practises. The temporary cessation of medicines during 
episodes of acute illness was not necessarily a straightfor-
ward concept to understand or communicate. Compar-
ative analysis of participants’ accounts highlighted a 
tension between ensuring reach in administration of 
the cards to at risk populations while being confident to 
ensure patient understanding of their purpose and use.
strengths and weaknesses of this study
Unlike an earlier study,20 a key strength of this evalua-
tion was to conduct an in-depth exploration of systematic 
rollout across a single healthcare setting. The study was 
hypothesis generating, and use of NPT provided a sensi-
tising framework for data collection and analysis.14–16 
Recognising that all theories have the potential to struc-
ture and constrain analysis, NPT was chosen as it ensured 
that a range of individual and collective working practises 
were considered during analysis.14 15 Methods to enhance 
the trustworthiness of the findings, including their trans-
ferability, entailed exploring types of work undertaken in 
both general practices and community pharmacies as well 
as their use by a range of health professionals in these 
different settings.21
The study entailed comparative analysis of both 
patient and professional accounts in order to explore 
their use in clinical interactions as well as in everyday 
life. Thematic analysis has illuminated a key tension 
between achieving reach while ensuring comprehen-
sion of the card and its instructions. However, a larger 
sample size might have resulted in the identification of 
additional themes that may have had an impact on this 
theoretical framework. Further research is required to 
enhance patient understanding and use. Professional 
accounts allowed descriptions of experiences of use by 
patients, though difficulties were encountered recruiting 
patient-participants who had experiences of having used 
a sick day guidance card at times of acute illness. It is 
important to acknowledge that only five patients were 
interviewed in spite of extensive recruitment efforts. It 
is not possible to determine how many patients received 
information packs as we did not ask practices to keep a 
record, to reduce work load. Health professionals did 
not always pass on the evaluation recruitment packs to 
patients, and the patients we interviewed had not used 
the cards to date, which could help to explain limited 
patient involvement. Workload pressures were cited as 
reasons for health professionals declining to participate 
in the evaluation.
During the course of the interviews, health practi-
tioners were asked about patient sense-making, use and 
appraisal of the guidance cards. In light of limited patient 
involvement, these accounts became more important. We 
acknowledge that they are third order interpretations; 
our interpretations of what health practitioners reported 
about patients’ sense-making, appraisal and use of the 
cards. However, the comparative approach taken has 
facilitated understanding of the pluralistic journeys of the 
cards and their intended and unintended messages and 
trajectories from card giver to patient across the 29 inter-
views. Future studies may benefit from sampling patients 
who have been coded in general practice as having been 
provided sick day guidance (ie, Read Code 8OAG. ‘Provi-
sion of information about AKI’22 and also who have been 
coded with an episode of acute illness (eg, gastroenteritis, 
acute respiratory infection). In doing so, this this would 
enable purposeful sampling according to medical history 
including evidence of multimorbidity. As stated in the 
CCG report, 106 000 cards (see table 1) were distributed 
across general practices and community pharmacies 
within the time frame of the project.19 However, commu-
nity pharmacists were not required to record adminis-
tration to patients and inaccuracies in coding in general 
practice limited the potential for a robust quantitative 
analysis. Future study design would benefit from greater 
alignment between quantitative and qualitative elements 
of an evaluation.19
comparison with other studies
In terms of professional responsibility, there are 
recognised boundaries to the role of GPs in supporting 
self-management.23 The findings of this study resonate 
and build on the results of previous research, which high-
lighted issues around the consistency of clinical message 
and the additional work required to reduce the risk of 
harm from AKI using medicines management interven-
tions.20 24 The intervention was conducted at a time when 
concern was raised that UK general practice workload 
may be at ‘saturation point.’25 Results suggested that this 
influenced engagement with the CCG-led initiative.
Though currently available through the Scottish Patient 
Safety Programme,6 the findings from this qualitative study 
resonate with recently published literature, which highlights 
a need for a more robust evidence base surrounding both 
the implementation and effectiveness of sick day guidance 
cards.26–28 A recent systematic review showed that ‘there is 
no evidence of the impact of drug cessation interventions 
on AKI incidence during intercurrent illness in primary or 
secondary care.’26 28 In terms of implementation, studies 
evaluating AKI interventions in secondary care indicate 
that establishing clinician approval is critical with a need for 
intervention design to take into account ‘how technologies, 
people and organisations dynamically interact’ in order for 
AKI interventions to become integrated into routine clinical 
practice.29 30 Interventions that disrupt workflow ‘may not 
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be sustainable even if there has been a positive impact on 
care.’29
Results from a population-based cohort study indicate 
that patient comorbidities including chronic kidney disease 
are much more strongly associated with AKI and that treat-
ment with either an ACE Inhibitor or an ARB is only asso-
ciated with a small increase in AKI risk.27That is, younger 
patients with limited comorbidity (eg, on ACEI for treat-
ment of hypertension) have a low absolute risk of AKI, while 
patients living with multimorbidity in whom there may be 
professional concerns about ensuring effective risk commu-
nication, have a much higher risk of AKI.27
Implications for clinicians, policy makers and future research
In the UK, NICE recommends raising awareness of AKI in 
higher risk population groups with specific reference to 
patients who: have existing CKD; have had a previous episode 
of illness complicated by AKI and/or have neurological or 
cognitive impairment and who may be reliant on carers for 
support with fluid intake during an acute illness (eg, those 
with cognitive impairment).31 This may help address a 
knowledge gap in patient and public understanding of the 
importance in the maintenance of kidney health. A survey 
conducted in 2014 on behalf of NHS England indicated that 
‘about half of the population in Great Britain do not think 
their kidneys make urine’ and ‘only an eighth (12%) of 
interviewees thought their kidneys had a role in processing 
medicines.’32 However, the findings from this study suggest 
an evidence base is urgently warranted to determine how 
best to resource effective self-management support for 
higher risk patient populations. Targeting patients who 
have had an episode of illness complicated by AKI may be 
particularly important. As a marker of vulnerability, data 
from a Welsh study showed that around 50% of their patient 
population died within 14 months; the study also revealed 
high rates of hospital readmission.33 Of the 733 patients 
discharged following a hospital admission complicated by 
AKI, there were 498 rehospitalisation events in a 6-month 
period.33
The NHS England Urgent and Emergency Care Review 
also emphasised the need for better support for people to 
self-care.34 Our analysis in conjunction with the research 
by Mansfield et al 27 suggests sick day guidance cards 
alone, that focus solely on temporary cessation of medi-
cines, are unlikely to be sufficient to reduce the harm 
associated with AKI. The CCG chose to implement the 
Scottish (NHS Highland) Medicine Sick Day Rules card 
without significant modification of content or format.6 
However, the current intervention may need modifying, 
to make it suitable for use with various populations, 
such as provision in languages other than English. For 
example, recognising the risks of the ‘triple whammy’ 
combination of NSAIDS prescribed in conjunction with 
diuretics and renin–angiotensin system inhibitors (ie, 
ACE inhibitors and ARBs), is there potential for misun-
derstanding if NSAIDS are included in a sick day guid-
ance card administered to patients with heart failure?35 
Both usability testing and experience-based codesign are 
methodological approaches that may optimise the devel-
opment of an intervention that takes into account patient 
and carer experience.36 The findings suggest other strat-
egies may need to be resourced to prevent AKI in people 
with complex health and social care needs such as those 
living with dementia. A key issue raised was to provide 
better education and support for carers (both profes-
sional and informal). The Royal College of General Prac-
titioners has provided guidance on the development of 
‘carer friendly’ practises and the establishment of Patient 
Participation Groups may be a mechanism to resource 
and integrate support for carers into the organisation of 
acute care.37 38
cOnclusIOn
The findings from this qualitative evaluation suggest that 
there are boundaries to the implementation of sick day 
guidance cards to prevent acute kidney injury in primary 
care. A common theme was the need to ensure patient 
understanding of their purpose and use. Communicating 
the concept of temporary cessation of medicines was a 
particular challenge and limited their administration 
to patient populations at higher risk of AKI, particu-
larly those with less capacity to self-manage. The analysis 
suggests that sick day guidance cards that focus solely on 
medicines management may be of limited benefit without 
either adequate resourcing or if delivered as a standalone 
intervention. Development and evaluation of a primary 
care intervention encompassing a range of initiatives to 
tackle the harm associated with AKI is warranted.
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